financetom
Personal Finance
financetom
/
Personal Finance
/
Research Alert: CFRA Maintains Strong Buy Opinion On Shares Of Newmont Corporation
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Research Alert: CFRA Maintains Strong Buy Opinion On Shares Of Newmont Corporation
Oct 24, 2025 5:08 AM

07:35 AM EDT, 10/24/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows:

We increase our 12-month target price by $19 to $113, as we value NEM at an EV/EBITDA of 8.0x our 2026 EBITDA estimate, a premium to NEM's three-year avg. forward EV/EBITDA of 6.7x and a premium to peers' average of 6.4x. We raise our 2025 EPS estimate by $0.41 to $6.21 and our 2026 EPS forecast by $0.51 to $7.76. We believe the premium valuation is justified by Newmont's ( NEM ) industry-leading scale and diversification, superior free cash flow generation capabilities (already achieving a full-year record of $4.5 billion in just nine months), and fortress balance sheet with near-zero net debt that enables consistent capital returns regardless of commodity price cycles. While 2026 production is expected toward the lower end of the guidance range due to planned mine sequencing, management expects to realize full benefits from cost savings initiatives. We view Newmont ( NEM ) as the premier gold equity with industry-leading assets, strong operational execution, and disciplined capital allocation.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Research Alert: CFRA Maintains Buy Opinion On Shares Of O'reilly Automotive Inc.
Research Alert: CFRA Maintains Buy Opinion On Shares Of O'reilly Automotive Inc.
Jul 8, 2025
12:30 PM EDT, 07/08/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We are updating our price target for the company's recently-completed 15-for-1 stock split. As a result, our price target goes to $100 from $1,500, based on a 2026 P/E of...
8 reasons to tap your home for cash: Expenses you can use home equity for
8 reasons to tap your home for cash: Expenses you can use home equity for
Jul 8, 2025
Key takeaways Home equity loans and HELOCs offer more money at a lower interest rate than credit cards or personal loans. Some of the most common (and best) reasons for using home equity include paying for home renovations, consolidating debt and covering emergency or unexpected costs. Although allowable, it's best to avoid using home equity for discretionary purchases and expenses....
Research Alert: CFRA Retains Buy Opinion On Shares Of Alnylam Pharmaceuticals, Inc.
Research Alert: CFRA Retains Buy Opinion On Shares Of Alnylam Pharmaceuticals, Inc.
Jul 8, 2025
01:00 PM EDT, 07/08/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We raise our 12-month target price to $367 from $343 based on our net present value (NPV) analysis. We lift our 2025 EPS estimate to $1.15 from $0.69, as we...
Research Alert: CFRA Keeps Buy Opinion On Shares Of Amphenol Corporation
Research Alert: CFRA Keeps Buy Opinion On Shares Of Amphenol Corporation
Jul 8, 2025
11:30 AM EDT, 07/08/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We raise our target price to $110 from $85, shifting to a P/E of 37x our 2026 EPS view, above APH's three-year average (~28x) on sizeable AI tailwinds. We also...
Copyright 2023-2026 - www.financetom.com All Rights Reserved